Clinical Trials Directory

Trials / Completed

CompletedNCT03656497

Classical Trigeminal Neuralgia and Sodium Channel Mutations

Status
Completed
Phase
Study type
Observational
Enrollment
33 (actual)
Sponsor
Danish Headache Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The most common cause of trigeminal neuralgia is considered to be a neurovascular contact. However, this etiological factor only seem to be present in half of the patient group. Thus the etiology of the other half is unknown. Gain-of function genetic mutations in voltage gated sodium channels have been hypothesized as playing a role in the etiology of trigeminal neuralgia but it has yet to be confirmed. In recent years gain-of-function mutations have been identified as a causative factor in other pain-diseases presenting with trigeminal neuralgia phenotypic similarities.

Detailed description

The aim of this study was to indentify VGSC gene mutations, specifically SCN9A, SCN10A and SCN11A genes, in a group of well characterized trigeminal neuralgia patients. Setting: The study will be conducted at The Danish Headache Center, Rigshospitalet - Glostrup, Denmark (inclusion of patients and written Informed Consent, patient interview, phenotyping/diagnosis, neurological examination, blood sample. Departments of Neurology and Clinical Genomics of the Maastricht University Medical Center, Maastricht, the Netherlands: Targeted NG Sanger Sequencing

Conditions

Interventions

TypeNameDescription
OTHERObservationalNo intervention is conducted as the study aim is to explore the link between pheno- and genetype of trigeminal neuralgia

Timeline

Start date
2015-11-01
Primary completion
2018-08-01
Completion
2018-08-01
First posted
2018-09-04
Last updated
2018-09-05

Source: ClinicalTrials.gov record NCT03656497. Inclusion in this directory is not an endorsement.